Scarica l'app Stockscreener
1.58
2.15%
-0.05
Dopo l'orario di chiusura:
1.60
0.02
+1.27%
Precedente Chiudi:
$1.63
Aprire:
$1.63
Volume 24 ore:
105.36K
Relative Volume:
0.46
Capitalizzazione di mercato:
$84.87M
Reddito:
-
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-1.881
EPS:
-0.84
Flusso di cassa netto:
$-18.45M
1 W Prestazione:
-4.49%
1M Prestazione:
-13.78%
6M Prestazione:
+19.92%
1 anno Prestazione:
+141.67%
Intervallo 1D:
$1.58
$1.67
Intervallo di 1 settimana:
$1.5802
$1.71
Portata 52W:
$0.61
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Nome
Quince Therapeutics Inc
Settore
Industria
Telefono
415-910-5717
Indirizzo
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Confronta QNCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.58 | 89.70M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Iniziato | Oppenheimer | Outperform |
Quince Therapeutics Inc Borsa (QNCX) Ultime notizie
Is Quince Therapeutics Inc. stock poised for growthPortfolio Update Report & Risk Controlled Swing Trade Alerts - Newser
Quince Therapeutics Inc. stock momentum explainedJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - Newser
Historical volatility pattern of Quince Therapeutics Inc. visualizedEarnings Summary Report & Daily Stock Momentum Reports - Newser
Quince Therapeutics Inc. stock prediction for this week2025 Trading Volume Trends & Fast Gain Stock Trading Tips - Newser
Analyzing drawdowns of Quince Therapeutics Inc. with statistical toolsLong Setup & Consistent Return Strategy Ideas - Newser
New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025July 2025 Spike Watch & Community Consensus Trade Signals - Newser
Is this a good reentry point in Quince Therapeutics Inc.Market Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
Quince Therapeutics Inc. stock chart pattern explainedJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser
Momentum divergence signals in Quince Therapeutics Inc. chartMarket Trend Report & Growth-Oriented Investment Plans - Newser
Building trade automation scripts for Quince Therapeutics Inc.July 2025 Sentiment & Fast Gain Swing Trade Alerts - Newser
Real time social sentiment graph for Quince Therapeutics Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Published on: 2025-08-19 14:00:59 - Newser
Is Quince Therapeutics Inc. a candidate for recovery playWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser
Ranking Quince Therapeutics Inc. among high performing stocks via toolsRate Hike & Scalable Portfolio Growth Ideas - Newser
Trend Reversal Possible in Quince Therapeutics Inc. Charts IndicateQuarterly Performance Summary & Comprehensive Market Scan Insights - 선데이타임즈
Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $8.14 Average Target Price from Brokerages - Defense World
Is it time to cut losses on Quince Therapeutics Inc.July 2025 Review & Technical Pattern Alert System - Newser
Should you hold or exit Quince Therapeutics Inc. nowJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - Newser
What candlestick patterns are forming on Quince Therapeutics Inc.2025 Market Trends & Detailed Earnings Play Strategies - Newser
Quince Therapeutics Inc. Approaches Support With Recovery in SightJuly 2025 Rallies & Free Safe Capital Growth Stock Tips - beatles.ru
Using data tools to time your Quince Therapeutics Inc. exit2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Price Channel Expanding on Quince Therapeutics Inc.’s ChartJuly 2025 Action & Weekly Top Gainers Trade List - newsyoung.net
Exit strategy if you’re trapped in Quince Therapeutics Inc.Forecast Cut & AI Driven Stock Movement Reports - Newser
What Fibonacci levels say about Quince Therapeutics Inc. reboundPortfolio Performance Report & Advanced Swing Trade Entry Alerts - Newser
Analyzing recovery setups for Quince Therapeutics Inc. investors2025 Performance Recap & AI Driven Stock Reports - Newser
Custom strategy builders for tracking Quince Therapeutics Inc.Earnings Overview Summary & Stock Portfolio Risk Management - Newser
Quince Therapeutics Inc Azioni (QNCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quince Therapeutics Inc Azioni (QNCX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thye Dirk | CEO AND CHIEF MEDICAL OFFICER |
Aug 29 '24 |
Buy |
0.69 |
77,500 |
53,475 |
766,941 |
1.34%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):